Silo Pharma Announces 1-for-15 Reverse Split, Shares to Drop to 1.08M
SILO sits 48% above its 52-week low of $0.221 on light trading volume (0.1× avg).
Summary
Silo Pharma announced a 1-for-15 reverse stock split, effective June 2, 2026, which will reduce its outstanding shares to approximately 1.084 million. This action is likely aimed at boosting the share price to meet Nasdaq's minimum bid requirement, given the company's current stock price of $0.3273 and recent financial challenges noted in its 10-K and 10-Q filings. While necessary for continued exchange listing, reverse splits are generally perceived negatively by the market, often signaling underlying financial distress and potentially leading to further stock price pressure. Post-split trading on Nasdaq will commence on June 3.
At the time of this announcement, SILO was trading at $0.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.22 to $1.01. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.